TRANSCAT INC. Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 6/6/2026)
| Balance Sheet | Total Assets | 480,487,000.00 | ROE | 62.57 % |
| Balance Sheet | Total Equity | 300,619,000.00 | ROA | 1.12 % |
| Cashflow | Capital Expenditures | -15,298,000.00 | P/FCF | 39.37 |
| Cashflow | Free Cash Flow | 19,553,000.00 | – | – |
| Cashflow | Operating Cash Flow | 34,850,000.00 | P/CF | 22.09 |
| Income | Earnings per Share (diluted) | 0.58 | Div. Yield | – |
| Income | Net Income | 5,376,000.00 | P/E | 142.02 |
| Income | Shares Outstanding | 9,345,000.00 | P/B | 2.56 |
| Income | Total Revenue | 331,877,000.00 | P/S | 2.32 |
Ratios calculated on: 10/14/2026
Company Description
Transcat, Inc. is a provider of calibration, repair, inspection and compliance services and distributor of professional grade handheld test, measurement and control instrumentation. The Company operates in two segments: Service and Distribution. The Company´s Service segment also offers compliance services, which include remediation, validation and analytical services primarily to pharmaceutical and FDA-regulated customers. Through its Distribution segment, the Company markets and sells national and brand instruments to approximately 15,000 customers. The Company provides products and services to pharmaceutical industry and FDA-regulated businesses, such as biotechnology and medical device manufacturing; industrial manufacturing companies; energy industry and power, natural gas and water utility companies; chemical process industry, and other industries which require accuracy in their processes and confirmation of the capabilities of their equipment.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.transcat.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more